Javascript must be enabled to continue!
Clinical heterogeneity in monogenic chylomicronaemia
View through CrossRef
Chylomicronaemia accompanies hypertriglyceridaemia, usually due to a polygenic predisposition in combination with secondary risk factors. Monogenic chylomicronaemia represents a small subgroup of patients with hypertriglyceridaemia. This article describes three patients and illustrates the heterogeneity in the presentation of monogenic chylomicronaemia. The first case is a man with mild hypertriglyceridaemia who is a compound heterozygote for two variants in the LMF1 gene, without relevant medical history. The second case is a woman who is a double heterozygote of variants in the LPL and APOA5 genes. She experienced pancreatitis. The third case is a man, with recurrent pancreatitis attributed to severe hypertriglyceridaemia and homozygous for a variant in the APOC2 gene. This article highlights that in patients with hypertriglyceridaemia, the absence of pancreatitis or the presence of mild hypertriglyceridaemia does not exclude monogenic chylomicronaemia. Genetic screening should be considered in patients with unexplained or severe hypertriglyceridaemia, to determine appropriate treatment and follow-up.
Title: Clinical heterogeneity in monogenic chylomicronaemia
Description:
Chylomicronaemia accompanies hypertriglyceridaemia, usually due to a polygenic predisposition in combination with secondary risk factors.
Monogenic chylomicronaemia represents a small subgroup of patients with hypertriglyceridaemia.
This article describes three patients and illustrates the heterogeneity in the presentation of monogenic chylomicronaemia.
The first case is a man with mild hypertriglyceridaemia who is a compound heterozygote for two variants in the LMF1 gene, without relevant medical history.
The second case is a woman who is a double heterozygote of variants in the LPL and APOA5 genes.
She experienced pancreatitis.
The third case is a man, with recurrent pancreatitis attributed to severe hypertriglyceridaemia and homozygous for a variant in the APOC2 gene.
This article highlights that in patients with hypertriglyceridaemia, the absence of pancreatitis or the presence of mild hypertriglyceridaemia does not exclude monogenic chylomicronaemia.
Genetic screening should be considered in patients with unexplained or severe hypertriglyceridaemia, to determine appropriate treatment and follow-up.
Related Results
Syndromic Monogenic Diabetes Genes Should be Tested in Patients With a Clinical Suspicion of MODY
Syndromic Monogenic Diabetes Genes Should be Tested in Patients With a Clinical Suspicion of MODY
At present, outside of
infancy, genetic testing for monogenic diabetes is typically for mutations in MODY
genes that predominantly result in isolated diabetes. Monogenic diabetes s...
Syndromic Monogenic Diabetes Genes Should be Tested in Patients With a Clinical Suspicion of MODY
Syndromic Monogenic Diabetes Genes Should be Tested in Patients With a Clinical Suspicion of MODY
At present, outside of
infancy, genetic testing for monogenic diabetes is typically for mutations in MODY
genes that predominantly result in isolated diabetes. Monogenic diabetes s...
C1q monogenic lupus: a case series and review
C1q monogenic lupus: a case series and review
Abstract
Objectives
Monogenic systemic lupus erythematosus (SLE) is caused by a single gene mutation. C1q deficiency is a rare b...
Monogenic in N-groups and its Subgroups
Monogenic in N-groups and its Subgroups
In this article we discuss the concept of monogenic -groups. First, we introduced the -monogenic -groups and we study its example and properties. Then we define monogenic in proper...
Abstract SY45-03: Capturing the therapeutic response heterogeneity at the functional level
Abstract SY45-03: Capturing the therapeutic response heterogeneity at the functional level
Abstract
Cancer heterogeneity is a major hurdle for the development of efficient therapeutic strategies. Patient selection strategies that include very specific m...
Safety and Efficacy of Atezolizumab in Ovarian Cancer
Safety and Efficacy of Atezolizumab in Ovarian Cancer
Abstract
Introduction
Although the efficacy of PD-L1 blockade has been evaluated in analyses that combine pharmacologically distinct antibodies, the specific efficacy and safety of...
565-P: A Case of Atypical Diabetes, Monogenic Diabetes
565-P: A Case of Atypical Diabetes, Monogenic Diabetes
A Case of Atypical Diabetes, Monogenic Diabetes, Monogenic diabetes formerly known as maturity onset diabetes of the young (MODY) is typically diagnosed in younger patients, usuall...
Exploring the genetic basis of childhood monogenic diabetes
Exploring the genetic basis of childhood monogenic diabetes
Monogenic diabetes is caused by one or even more genetic variations, which may be uncommon yet have a significant influence and cause diabetes at an early age. Monogenic diabetes a...

